KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Return on Equity (2016 - 2025)

Arbutus Biopharma (ABUS) has disclosed Return on Equity for 12 consecutive years, with 0.44% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 24.0% to 0.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.44% through Dec 2025, up 24.0% year-over-year, with the annual reading at 0.39% for FY2025, 29.0% up from the prior year.
  • Return on Equity hit 0.44% in Q4 2025 for Arbutus Biopharma, up from 0.53% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.44% in Q2 2022 to a low of 0.87% in Q1 2025.
  • Historically, Return on Equity has averaged 0.59% across 5 years, with a median of 0.6% in 2021.
  • Biggest five-year swings in Return on Equity: surged 136bps in 2021 and later dropped -19bps in 2025.
  • Year by year, Return on Equity stood at 0.51% in 2021, then increased by 3bps to 0.49% in 2022, then tumbled by -31bps to 0.65% in 2023, then fell by -6bps to 0.68% in 2024, then soared by 35bps to 0.44% in 2025.
  • Business Quant data shows Return on Equity for ABUS at 0.44% in Q4 2025, 0.53% in Q3 2025, and 0.67% in Q2 2025.